Ignite Creation Date:
2024-05-06 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 2:17 PM
Study NCT ID:
NCT05107596
Status:
RECRUITING
Last Update Posted:
2022-11-23
First Post:
2021-10-07
Brief Title:
Evaluation of CCR2 in Patients Post Myocardial Infarction
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Study Overview
Official Title:
Preliminary Evaluation of 64Cu-DOTA-ECL1i in Patients Post-ST-Elevation Myocardial InfarctionSTEMI
Status:
RECRUITING
Status Verified Date:
2022-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine the feasibility of 64Cu-DOTA-ECL1i an investigational PET imaging drug at the cellular level in the myocardium for individuals who have suffered a heart attack or who have other inflammatory heart disease
Detailed Description:
To determine the feasibility of 64Cu-DOTA-ECL1i to detect CCR2monocytes and macrophages which are cells that are responsible for protecting tissues from foreign substances in the myocardium by PETMR and PETCT
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None